Spineart, a Switzerland based SJE Group investment, has announced that its product, BAGUERA® C, has been officially included on the Australian Government's Prostheses List.
The Prostheses List is the Australian Government's list of surgically implanted prostheses, human tissue items and other medical devices that private health insurers must pay benefits under certain conditions. The March 2020 list can be found here.
The SJE Group congratulates Jérôme Levieux and Stéphane Mugnier-Jacob (joint CEOs and Co Founders, Spineart) and the rest of the Executive team.
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. The company is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.